Testosterone Cypionate USP

Its main use is to treat males who have a deficiency or absence of natural testosterone due to conditions like primary hypogonadism (testicular failure) or hypogonadotropic hypogonadism (pituitary/hypothalamic issues). It is also used off-label for gender-affirming hormone therapy in transgender men and, in some cases, for delayed puberty in boys or as part of breast cancer treatment in women.

Testosterone cypionate is indicated for replacement therapy in males who have conditions associated with a deficiency or absence of endogenous testosterone
The typical dosage for a hypogonadal male is 50 to 400 mg every two to four weeks, adjusted based on the patient’s response and testosterone blood levels

Testosterone cypionate is indicated for replacement therapy in males who have conditions associated with a deficiency or absence of endogenous testosterone (hypogonadism). This includes primary hypogonadism (testicular failure) and hypogonadotropic hypogonadism (pituitary-hypothalamic injury). It is also used off-label for transmasculine hormone replacement therapy in transgender men.